Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Molina Healthcare ( (MOH) ).
On November 17, 2025, Molina Healthcare announced the pricing of $850 million in senior notes due 2031, with a 6.500% interest rate, to be sold in a private offering. The net proceeds, estimated at $838 million, will be used for general corporate purposes, including repaying outstanding loans, impacting the company’s financial strategy and market positioning.
The most recent analyst rating on (MOH) stock is a Buy with a $165.00 price target. To see the full list of analyst forecasts on Molina Healthcare stock, see the MOH Stock Forecast page.
Spark’s Take on MOH Stock
According to Spark, TipRanks’ AI Analyst, MOH is a Neutral.
Molina Healthcare’s overall stock score is primarily impacted by its strong revenue growth but challenged by profitability and cash flow issues. The technical analysis indicates bearish momentum, which could lead to further price declines. The valuation suggests potential undervaluation, but the lack of a dividend yield may deter some investors.
To see Spark’s full report on MOH stock, click here.
More about Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces.
Average Trading Volume: 1,503,024
Technical Sentiment Signal: Sell
Current Market Cap: $7.07B
Learn more about MOH stock on TipRanks’ Stock Analysis page.